Company: FENC
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001558370-25-005563
Chunk: 21

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 21
---
 period, |

(ii)acceleratethe expiry ofany offeringperiod,(iii)reducethediscount applicableindeterminingthe purchaseprice for Sharesof anyoffering period,(iv)amend the Plan to conformwith thesafe harbor definition underthe FinancialAccountingStandardsBoardAccountingStandardsCodificationTopic718(oranysuccessorthereto), (v)alterthepurchasepriceforSharesunderanyofferingperiod,(vi)reducethemaximumnumberofSharesthat may be purchased in any offering period, (vii)reduce the maximum percentage of Compensation a grantee may elect to set aside as contributions or (viii) take any combination of the foregoing actions. AcopyoftheEquityIncentivePlanreflectingtheproposedamendmentsisattachedtothiscircularasSchedule “B”. OnApril 24,2025,theCorporation’sboardofdirectorsapproved,subjecttotheapprovaloftheCorporation’scommon shareholders, amending the Equity Incentive Plan to: (i) increase the number of common shares available for issuance under the Equity Incentive Plan (excluding common shares issued prior to the date of the Meeting pursuant to the exercise of options and vesting of RSUs) to 8,500,000 common shares, representing approximately 30.8% of thetotalissuedandoutstandingcommonsharesasofthedateofthiscircular;(ii)addprovisionsrelatingtoanemployee stock purchase program under the Equity Incentive Plan. TheboardofdirectorsthereforerecommendsthatShareholders,otherthantheEligibleInsiders(definedbelow),approve the following resolutions: “BEITRESOLVED THAT:

| 1. | the Corporation’s Equity Incentive Plan be and is hereby amended to |

(i)confirm that the number of common shares issuable pursuant to the exercise of stock options under the Equity Incentive Plan be increased such that the maximum number of common shares that may be issued pursuant to the grant of stock options or other awards under the Equity Incentive Plan (excluding the common sharespreviouslyissuedpursuanttotheexerciseofoptionsandvestingofRSUsprior to June 3, 2025) will be 8,500,000, and (ii)add certain employee share purchase program related provisions, ineachcaseasdescribedintheManagementProxyCircularofFennecPharmaceuticalsInc.datedApril7, 202